HOLLAND, Mich., March 14, 2019—Shoulder Innovations (SI) is pleased to announce the successful first human use of its new InSet Humeral short stem system. The new product represents SI’s latest addition to its InSet Shoulder System, which also includes the InSet Glenoid.
David Blue, Chief Commercial Officer of Shoulder Innovations, said, “This is an exciting day for Shoulder Innovations as we continue to roll out the next phase of the InSet technology platform. This combined with our very successful InSet Glenoid implant provides the next generation of innovative technology for shoulder arthroplasty, while providing to smallest instrument and implant footprint on the market today.”
About Shoulder Innovations:
Shoulder Innovations, LLC is a medical device development company which designs and commercializes innovative products which demonstrate the potential for improved patient care and reduced overall cost to the healthcare system.
Leveraging its breakthrough, patented, inset glenoid design, Shoulder Innovations is commercializing a shoulder replacement implant system focused on improving outcomes related to the greatest cause of shoulder replacement failure: glenoid loosening.
The InSet technology has been shown in testing to significantly reduce glenoid implant micro-motion and simplifies the surgical technique, potentially reducing complications or increase implant longevity.